David Clements, M.S.
Managing Officer - Vaccines
Alan Johnson, Ph.D.
Managing Officer - Chemistry
Marcia McKinnon
Managing Officer - Finance
Sean O’Malley, Ph.D.
Principal Scientist
David Clements, M.S.
Managing Officer - Vaccines
Alan Johnson, Ph.D.
Managing Officer - Chemistry
Marcia McKinnon
Managing Officer - Finance
Sean O’Malley, Ph.D.
Principal Scientist
Debra Beresini
Director
Debra is an experienced leader, manager, investor, and entrepreneur. In 1997, she co-founded invencor, inc. based in the San Francisco Bay Area, and has since served as its CEO. Over the years, invencor has managed debt and equity funds and consulted with lending institutions on credit facilities for startup companies. While invencor continues to serve in that role, its primary focus is to support women entrepreneurs and those rising through the ranks of their companies. In 2013, Debra was named one of the “100 Most Influential Women in Silicon Valley” by the Silicon Valley Business Journal. She was on the Board of Trustees for VentureCapital.org (VCO) for 17 years with 5 of those years as Chair. During her time at VCO, she and the team founded WeROC (Women Entrepreneurs Realizing Opportunities for Capital). Through VCO, women are coached on their presentation skills in order to raise money from investors at the WeROC conferences. She was previously Senior Vice President and Manager of the National Division at Silicon Valley Bank. She graduated Summa Cum Laude from Dominican College (now Dominican University) and has an MBA from the Jack Welch Management Institute, Strayer University.
Debra also runs a family-owned vineyard, Beresini Winery, with her husband, Steve, in Carneros, Napa producing Pinot Noir, Chardonnay, and Pinot Noir Rose. Recently, they opened a Winery and Tasting Room for their award-winning wines in Glen Ellen, California.
Mark Bogart. Ph.D.
Director
Mark is a highly successful biotech entrepreneur. He discovered and commercialized a key part of the maternal serum triple test for Down’s Syndrome carried out on pregnant women. The test became part of the standard of care for pregnant women in the first world. Dr. Bogart is an investor in over a dozen biomedical and technology companies and has served on the Boards of Genetic Information Management Systems, Kuehnle Agrosystems, Kona Blue Water Farms, and Hawaii Biotech, Inc. He did his post-doctoral training in Genetics at UCSD and is Board Certified in Clinical Cytogenetics by the American Board of Medical Genetics and was a founding member of the American College of Medical Genetics. During his academic career in clinical and research genetics Dr. Bogart published over 50 scientific articles and received three patents. Transitioning from academics to business he started a patent management and licensing company (Biomedical Patent Management Corp.) and a diagnostic genetics laboratory (Mid-Pacific Genetics) which was subsequently sold to the Queen’s Medical Center in Honolulu. He has served on a number of State committees and non-profit Boards in both California and Hawaii. He received a BA from the University of California, San Diego (UCSD) and a PhD in a joint program between UCSD and San Diego State University.
Michele Yelmene
Director
Michele has over 35 years of hands-on biotech and pharmaceutical industry experience in all aspects of drug development from bench research and clinical trial design through product registration and post marketing activities. Her breadth of experience includes the submission of over 100 INDs with 18 drugs/biologics achieving domestic and international regulatory marketing approval.
She has designed, conducted, and reported global clinical studies in a wide variety of therapeutic areas, including infectious diseases, metabolic and endocrine disorders, and oncology. She has also implemented and overseen Quality Systems and manufacturing for Phase 1 through commercial launch of new drugs and biologics in addition to preparing for and hosting inspections by FDA and other regulatory authorities.